The 4-cm threshold and malignancy yield in surgically treated Bethesda IV thyroid nodules
European Journal of Surgical Oncology · 2027-01 · 53 (1) · 112351
DOI: 10.1016/j.ejso.2026.112351 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2027-01. Verfasst von Fabio Medas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, University of Cagliari, SS 554, Cittadella Universitaria di Monserrato, 09042, Monserrato, CA, Italy. Electronic add…. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: We examined whether the 40-mm threshold identifies a higher malignant proportion among surgically treated Bethesda IV nodules. MATERIALS AND METHODS: This single-center retrospective cohort included adults with a recorded ultrasound diameter and assignable final histology. All cytology was assessed by the same cytopathologist. Diameter was analysed continuously, with a restricted cubic spline, and at 40 mm. Additional models included recorded ultrasound features. Carcinoma characteristics were examined once per patient as exploratory outcomes. RESULTS: The cohort comprised 676 nodules from 644 operations in 643 patients; 219 were malignant (32.4%). The malignant proportion was 28.8% at ≥40 mm and 33.2% below 40 mm (difference, -4.3% (95% CI, -12.8 to 5.2); adjusted OR, 0.80 (0.50-1.27)). The relation with diameter was nonlinear (P < 0.001). Among 627 nodules with recorded echogenicity, the OR after adding hypoechogenicity was 0.83 (0.51-1.36). In the exploratory analysis of 210 patients with differentiated thyroid carcinoma, adverse pathology occurred in 16/34 cancers ≥40 mm and 55/176 smaller cancers, largely reflecting angioinvasion (15/34 vs 15/176). CONCLUSION: The 40-mm comparison did not demonstrate a higher malignant proportion within this surgical cohort; equivalence was not established. The secondary angioinvasion finding requires confirmation. These data do not establish the comparative benefits of different operations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Sciences, University of Cagliari, SS 554, Cittadella Universitaria di Monserrato, 09042, Monserrato, CA, Italy. Electronic address: fabiomedas@unica.it.
- Department of Surgical Sciences, University of Cagliari, SS 554, Cittadella Universitaria di Monserrato, 09042, Monserrato, CA, Italy.
Zitieren
APA
Medas, F., Cappellacci, F., Canu, G. L., Noli, E., Piras, S., & Calò, P. G. (2027). The 4-cm threshold and malignancy yield in surgically treated Bethesda IV thyroid nodules. European Journal of Surgical Oncology, 53(1), 112351. https://doi.org/10.1016/j.ejso.2026.112351
Vancouver
Medas F, Cappellacci F, Canu GL, Noli E, Piras S, Calò PG. The 4-cm threshold and malignancy yield in surgically treated Bethesda IV thyroid nodules. European Journal of Surgical Oncology. 2027;53(1):112351. doi:10.1016/j.ejso.2026.112351
BibTeX
@article{Medas2027,
author = {Medas, Fabio and Cappellacci, Federico and Canu, Gian Luigi and Noli, Eleonora and Piras, Stefano and Calò, Pietro Giorgio},
title = {The 4-cm threshold and malignancy yield in surgically treated Bethesda IV thyroid nodules},
journal = {European Journal of Surgical Oncology},
year = {2027},
volume = {53},
number = {1},
pages = {112351},
doi = {10.1016/j.ejso.2026.112351}
}
EUVIMED